DYAI Dyadic International, Inc. Total Debt to Capital

Market dynamics reflected in the quotes on GURU.Markets show that the total debt-to-equity ratio for Dyadic International (DYAI) is 0.00. The business relies on the implementation of the C1 system for the rapid creation of pharmaceuticals, aiming to capture niches in virology through B2B licenses. Dyadic International (DYAI) acts as a technological ally to global laboratories by scaling protein synthesis and minimizes logistical risks through safety stocks and route variability.

This ratio measures the proportion of debt obligations to total asset value, determining the business's degree of reliance on external financing relative to its own equity. By analyzing the capital structure in terms of debt-to-equity, an investor assesses the financial autonomy of Dyadic International (DYAI), which is supported by stable vaccine licensing and minimal geopolitical risks within the legal framework.